Source: Eur Respir Rev, 29 (157) 200310; 10.1183/16000617.0310-2020



Rating:

Share or cite this content

Citations should be made in the following way:
Nicolas Roche, Thomy Tonia, Andrew Bush, Chris Brightling, Martin Kolb, Anh Tuan Dinh-Xuan, Marc Humbert, Anita Simonds, Yochai Adir. Guidance production before evidence generation for critical issues: the example of COVID-19. Eur Respir Rev, 29 (157) 200310; 10.1183/16000617.0310-2020

Member's Comments

No comment yet.

Related content which might interest you: Producing documents for the ERS: types, requirements and processes Source: Annual Congress 2013 –How to produce top quality ERS Guidelines Year: 2013 Clinical use of new and repurposed drugs: the role and contribution of the ERS collaborative projects Source: International Congress 2017 – In the frontline of the fight against tuberculosis Year: 2017 Evidence provided by recent meta-analyses on treatment: what is new? Source: Annual Congress 2012 - PG7 TB and MDR-/XDR-TB: what is new in diagnosis, treatment and follow-up (TB PAN-NET) Year: 2012 Formulating recommendations and identifying areas of future research - Panel discussion and protocol Source: Research Seminar 2009 - The rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs) Year: 2009 Universal use of face masks for success against COVID-19: evidence and implications for prevention policies Source: Eur Respir J, 55 (6) 2001260; 10.1183/13993003.01260-2020 Year: 2020 Candidate selection and management: specific controversial and ethical issues Source: ERS Course 2016 Year: 2016 Establishing new treatments: the role of RCTs Source: Virtual Congress 2020 – Tuberculosis: learning from the WHO global health emergencies Year: 2020 Late Breaking Abstract - Evidence of target engagement and pathway modulation: biomarker analysis of the phase 1b inhaled seralutinib study Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 Increasing implementation and delivery of pulmonary rehabilitation: key messages from the new ATS/ERS policy statement Source: Eur Respir J 2016; 47:1336-1341 Year: 2016 Panel discussion: identify concrete areas/topics where collaboration at EU-level is necessary. Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research Year: 2013 Harnessing big data for evaluation and regulation of medicines Source: Virtual Congress 2021 – Artificial intelligence and big data Year: 2021 Describing what evidence and outcomes to use in guidelines Source: Annual Congress 2008 - Guideline development workshop summary: ATS/ERS integrating and coordinating efforts in COPD Year: 2008 Targeting the arginase pathway: potential developments as new avenues for treatment Source: Annual Congress 2004 - Arginase: a novel target and marker for asthma? Year: 2004 Prevention: educational issues and recommendations for early recognition Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-22-7, page=89 Year: 2005